<unk> (oral) is an estrogen/progestin combination that is FDA approved for the treatment of moderate to severe vasomotor symptoms due to menopause, moderate to severe symptoms of vulvar and vaginal atrophy due to menopause and prevention of postmenopausal osteoporosis.   Common adverse reactions include edema, chloasma, hirsutism, loss of scalp hair, weight increased, abdominal pain, bloating symptom, headache, breast tenderness, disorder of menstruation, pain of breast, swelling of breast, vaginal discomfort, withdrawal bleeding, upper respiratory infection and pain.
Estradiol and norethindrone acetate 
Estradiol valerate and estradiol valerate/dienogest
Desogestrel and Ethinyl Estradiol
Ethynodiol diacetate and ethinyl estradiol
Conjugated estrogens and medroxyprogesterone acetate
Norelgestromin and Ethinyl Estradiol
Norgestrel and Ethinyl estradiol
Norgestimate and Ethinyl estradiol